Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2ENDO OPERATIONS

02 4Future Health Pharma GmbH

03 7Noden Pharma

04 11Novartis Pharmaceuticals Corporation

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE

Brand Name : TEKTURNA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2007-03-05

Application Number : 21985

Regulatory Info : RX

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE

Brand Name : TEKTURNA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE

Packaging :

Approval Date : 2007-03-05

Application Number : 21985

Regulatory Info : RX

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE

Brand Name : TEKTURNA HCT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2008-01-18

Application Number : 22107

Regulatory Info : DISCN

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE

Brand Name : TEKTURNA HCT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2008-01-18

Application Number : 22107

Regulatory Info : DISCN

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE

Brand Name : TEKTURNA HCT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2008-01-18

Application Number : 22107

Regulatory Info : DISCN

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE

Brand Name : TEKTURNA HCT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2008-01-18

Application Number : 22107

Regulatory Info : DISCN

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE

Brand Name : TEKTURNA

Dosage Form : CAPSULE, PELLET;ORAL

Dosage Strength : EQ 37.5MG BASE

Packaging :

Approval Date : 2017-11-14

Application Number : 210709

Regulatory Info : DISCN

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; VALSARTAN

Brand Name : VALTURNA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;160MG

Packaging :

Approval Date : 2009-09-16

Application Number : 22217

Regulatory Info : DISCN

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; VALSARTAN

Brand Name : VALTURNA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;320MG

Packaging :

Approval Date : 2009-09-16

Application Number : 22217

Regulatory Info : DISCN

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE

Brand Name : TEKAMLO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;EQ 5MG BASE

Packaging :

Approval Date : 2010-08-26

Application Number : 22545

Regulatory Info : DISCN

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE

Brand Name : TEKAMLO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;EQ 10MG BASE

Packaging :

Approval Date : 2010-08-26

Application Number : 22545

Regulatory Info : DISCN

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE

Brand Name : TEKAMLO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 5MG BASE

Packaging :

Approval Date : 2010-08-26

Application Number : 22545

Regulatory Info : DISCN

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE

Brand Name : TEKAMLO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 10MG BASE

Packaging :

Approval Date : 2010-08-26

Application Number : 22545

Regulatory Info : DISCN

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : AMTURNIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE;EQ 5MG BASE;12.5MG

Packaging :

Approval Date : 2010-12-21

Application Number : 200045

Regulatory Info : DISCN

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : AMTURNIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 5MG BASE;12.5MG

Packaging :

Approval Date : 2010-12-21

Application Number : 200045

Regulatory Info : DISCN

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : AMTURNIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 5MG BASE;25MG

Packaging :

Approval Date : 2010-12-21

Application Number : 200045

Regulatory Info : DISCN

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : AMTURNIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 10MG BASE;12.5MG

Packaging :

Approval Date : 2010-12-21

Application Number : 200045

Regulatory Info : DISCN

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE

Brand Name : AMTURNIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE;EQ 10MG BASE;25MG

Packaging :

Approval Date : 2010-12-21

Application Number : 200045

Regulatory Info : DISCN

Registration Country : USA

blank

19

ENDO OPERATIONS

Country
2024 ACI Convention
Not Confirmed
arrow

ENDO OPERATIONS

Country
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE

Brand Name : ALISKIREN HEMIFUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2019-03-22

Application Number : 206665

Regulatory Info : RX

Registration Country : USA

blank

20

ENDO OPERATIONS

Country
2024 ACI Convention
Not Confirmed
arrow

ENDO OPERATIONS

Country
arrow
2024 ACI Convention
Not Confirmed

ALISKIREN HEMIFUMARATE

Brand Name : ALISKIREN HEMIFUMARATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 300MG BASE

Packaging :

Approval Date : 2019-03-22

Application Number : 206665

Regulatory Info : RX

Registration Country : USA

blank